Alexander Kolevzon MD

Psychiatry•New York, NY

Child & Adolescent Psychiatry

Professor, Psychiatry and Pediatrics, Icahn School of Medicine

Join to View Full Profile

1 Gustave L Levy Pl# 1230New York, NY 10029
Phone+1 212-659-9134
Fax+1 212-996-8931

Education & Training

Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Child and Adolescent Psychiatry, 2003 - 2005
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Psychiatry, 2000 - 2003
Tel Aviv University SacklerClass of 2000

Certifications & Licensure

NY State Medical License 2001 - 2027
FL State Medical License 2015 - 2017
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Clinical Trials

Trichuris Suis Ova in Autism Spectrum Disorders Start of enrollment: 2012 Nov 01
Completed
Phase 1
Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome) Start of enrollment: 2012 Feb 01
Completed
Phase 2
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome Start of enrollment: 2014 Jan 01
Completed
Phase 2
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors Start of enrollment: 2014 Aug 01
Completed
Phase 2
A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder Start of enrollment: 2014 May 01
Terminated
Phase 2
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
ACTIVE_NOT_RECRUITING
Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome Start of enrollment: 2016 Apr 29
Completed
Phase 2
AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy Start of enrollment: 2018 May 30
COMPLETED
PHASE2
DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. Start of enrollment: 2018 May 22
Recruiting
FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. Start of enrollment: 2016 Mar 28
RECRUITING
ADNP Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing ADNP-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. Start of enrollment: 2017 Nov 14
RECRUITING
Growth Hormone Treatment in Children With Phelan McDermid Syndrome Start of enrollment: 2019 Sep 13
Completed
Phase 2
Approach to Dance for Autism Start of enrollment: 2024 Jul 17
COMPLETED
NA
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Genome Sequencing Uncovers Additional Findings in Phelan-McDermid Syndrome.
Rachel Gore Moses, Morgan Similuk, Alexandra Hehn, Rylee Duncan, Margaret Pekar
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics. 2025-10-01
8 citations
Racial Differences in the Prevalence of Autism Spectrum Disorder: A Systematic Review.
Zachary Gallin, Ana M Kolevzon, Abraham Reichenberg, Sidney H Hankerson, Alexander Kolevzon
Journal of Autism and Developmental Disorders. 2025-09-01
1 citations
Genetic Subtypes of Phelan-McDermid Syndrome Exhibit Similar Rates of Change Despite Differences in Level of Impairment in Developmental Constructs.
Tess Levy, Cristan Farmer, Siddharth Srivastava, Kristina Johnson, Jadyn Trayvick
American Journal on Intellectual and Developmental Disabilities. 2025-09-01

Press Mentions

Autism Experts Rebuff HHS Report on Tylenol-Autism Link, New Indication for LeucovorinSeptember 23rd, 2025
What Do We Know About the Causes of Autism?May 5th, 2025
Clinical Trial for Rare Genetic Disease Gets Assistance from Artificial IntelligenceNovember 4th, 2022
Join now to see all

Grant Support

Electrophysiological Markers for Interventions in Phelan-McDermid Syndrome and Idiopathic AutismICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2018–2025
OPEN Label Risperidone In Children And Adolescents With Autistic DisorderNational Center For Research Resources2009
Effect Of Fluoxetine Orally Dissolving Tablet (ODT) On Repetitive BehaviorsNational Center For Research Resources2008

Alexander Kolevzon MD

Dr. Kolevzon is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Grant Support

Viewing the full profile is available to verified healthcare professionals only.